Chinese biotech robotics firm MegaRobo Co. Ltd. today announced it raised $200 million in new funding to invest in its core technology and expand its automated life sciences infrastructure for increasingly complex physical systems.
Founded in 2016, MegaRobo builds robotic systems that let artificial intelligence software run physical experiments, alongside precision measurement and inspection tools for manufacturers.
Investors joining the round included Oman Investment Authority, Asia Investment Capital, Granite Asia, Sinovation Ventures and CMB International. The company raised $600 million to date across multiple funding rounds, including nearly $300 million in Series C during 2022.
“The first generation of AI learned from humanity’s accumulated knowledge. The next generation will increasingly learn by acting in the physical world — through experiments, production and continuous feedback,” said founder and Chief Executive Daniel Huang. “That shift changes AI from a system that interprets the world into one that can help create new knowledge, materials, processes and products.”
The company’s two most prominently marketed offerings are Megalaxy Lab, an AI-connected experimental platform and CellVue T2000, its automated cell-imaging instrument. Both appear on the company’s English-language homepage. MegaRobo also sells more specialized lab equipment, including the Auflo sample-preparation workstation and the Seloris cell culturing automation system.
The key distinction is that Megalaxy Lab is the public face for the company’s AI-for-science strategy, while CellVue and other systems represent concrete examples of the instruments it builds for the industry.
The company said through Megalaxy it is making real-world experimentation programmable and accessible. Researchers and AI agents can configure experiments, route them through automated laboratory systems, track execution, receive structured, machine-readable results, and feed them directly into the next cycle of scientific reasoning. This includes virtual large data readouts that can be amplified as digital twins representing the scientific data, protein design, biochemistry and other properties.
MegaRobo said it is working together with industry partners, including Tencent Cloud and Twist Bioscience, to expand its capability in the AI Science community with the launch of Poreva Open, a global AI protein design challenge open to all models and technical approaches. Megalaxy will provide wet-lab validation for more than 10,000 protein design sequences, creating an opportunity to test models against real experimental data.
The company is also developing the One Intelligence Stack as a common technology foundation for instruments, machines, materials processes and real-world feedback. Not just as a collection of isolated AI applications and products, but as a chain infrastructure that enables AI to act, learn and observe across complex physical environments.
